From: Survivin and angiotensin-converting enzyme polymorphisms with risk of colorectal cancer: a systematic review and meta-analysis
Genotype
OR (95% CI)
P
Ph
I 2 (%)
Model
D vs. I
0.96 (0.84, 1.08)
0.48
0.87
0
Fixed
DD vs. II
0.86 (0.66, 1.12)
0.25
DD + ID vs. II
0.97 (0.79, 1.19)
0.77
0.12
46
DD vs. ID + II
0.91 (0.74, 1.12)
0.39
0.93